menu toggle

April 24, 2026

FAVLYXA™ now available

FAVLYXA™ (fluorouracil) is a nucleoside metabolic inhibitor indicated for the treatment of patients with:

  • Adenocarcinoma of the Colon and Rectum
  • Adenocarcinoma of the Breast
  • Gastric Adenocarcinoma
  • Pancreatic Adenocarcinoma

Please see full prescribing information here.

We are NABP accredited